| WBYNZQXAAWPAGR-UHFFFAOYSA-N |
CS-2866 |
1637300-25-4 |
| NIBR189 |
NIBR189 |
1599432-08-2 |
| SGC0946 |
SGC0946 |
1561178-17-3 |
| XEN445 |
(S)-2-(3-(PYRIDIN-2-YLMETHOXY)PYRROLIDIN-1-YL)-5-(TRIFLUOROMETHYL)BENZOIC ACID. HCL |
1515856-92-4 |
| ODM203 |
ODM203 |
1430723-35-5 |
| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 |
1429881-91-3 |
| Cilofexor |
CILOFEXOR; GS-9674; GS 9674; GS9674; |
1418274-28-8 |
| GC376 |
GC376 |
1416992-39-6 |
| JNK-IN-8 |
JNK-IN-8 |
1410880-22-6 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
EPZ005687 |
1396772-26-1 |
| BIX 01294 |
BIX 01294三盐酸盐水合物 |
1392399-03-9 |
| Verdinexor (KPT-335) |
Verdinexor (KPT-335) |
1392136-43-4 |
| LY3023414 |
LY-3023414 |
1386874-06-1 |
| CO-1686 |
CO1686 |
1374640-70-6 |
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
| N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide |
AGI-5198 (IDH-C35) |
1355326-35-0 |
| EW-7197 |
EW-7197 |
1352608-82-2 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
GSK126 |
1346574-57-9 |
